Radionuclide imaging of drug delivery for patient selection in targeted therapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radionuclide imaging of drug delivery for patient selection in targeted therapy
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume 11, Issue 2, Pages 175-185
Publisher
Informa Healthcare
Online
2014-01-09
DOI
10.1517/17425247.2014.870552
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized phase II/III study of the anti-IGF-1R antibody MK-0646 (dalotuzumab) in combination with cetuximab (Cx) and irinotecan (Ir) in the treatment of chemorefractory metastatic colorectal cancer (mCRC) with wild-type (wt) KRAS status.
- (2017) D. J. Watkins et al. JOURNAL OF CLINICAL ONCOLOGY
- The promise of anti-ErbB3 monoclonals as new cancer therapeutics
- (2015) Luigi Aurisicchio et al. Oncotarget
- Bevacizumab-Induced Normalization of Blood Vessels in Tumors Hampers Antibody Uptake
- (2013) M. Arjaans et al. CANCER RESEARCH
- Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies
- (2013) Sandra Heskamp et al. INTERNATIONAL JOURNAL OF CANCER
- MET As a Possible Target for Non–Small-Cell Lung Cancer
- (2013) Ahad A. Sadiq et al. JOURNAL OF CLINICAL ONCOLOGY
- Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs
- (2012) Astrid A.M. Van der Veldt et al. CANCER CELL
- Drug Development: Portals of Discovery
- (2012) S. E. Bates et al. CLINICAL CANCER RESEARCH
- Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model
- (2012) C. V. Pastuskovas et al. MOLECULAR CANCER THERAPEUTICS
- Lapatinib and 17AAG Reduce 89Zr-Trastuzumab-F(ab′)2 Uptake in SKBR3 Tumor Xenografts
- (2012) Thijs H. Oude Munnink et al. MOLECULAR PHARMACEUTICS
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer
- (2011) A A Memon et al. BRITISH JOURNAL OF CANCER
- Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors
- (2011) S. I. Rudnick et al. CANCER RESEARCH
- Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography
- (2011) Arifudin Achmad et al. CANCER SCIENCE
- Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507
- (2011) E. D. G. Fleuren et al. CLINICAL CANCER RESEARCH
- R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
- (2011) Alberto S. Pappo et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung Cancer
- (2011) Suresh S. Ramalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group
- (2011) Suman Malempati et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Imaging with 11C-PD153035 PET/CT Predicts Survival in Non-Small Cell Lung Cancer Treated with EGFR-TKI: A Pilot Study
- (2011) X. Meng et al. JOURNAL OF NUCLEAR MEDICINE
- Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule 111In-DOTA-ZIGF1R:4551
- (2011) V. Tolmachev et al. JOURNAL OF NUCLEAR MEDICINE
- Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation in the Epidermal Growth Factor Receptor
- (2011) Britta Weber et al. Journal of Thoracic Oncology
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prednisolone-induced changes in gene-expression profiles in healthy volunteers
- (2011) Erik JM Toonen et al. PHARMACOGENOMICS
- Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT
- (2011) H. H. Yeh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- A Message from the New Editor-in-Chief
- (2010) G. C. Prendergast CANCER RESEARCH
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
- (2010) E C Dijkers et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels
- (2010) Vladimir Tolmachev et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radiolabeled cetuximab: Dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
- (2010) Bianca A.W. Hoeben et al. INTERNATIONAL JOURNAL OF CANCER
- ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model
- (2010) S. Heskamp et al. JOURNAL OF NUCLEAR MEDICINE
- 111In-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vascular Endothelial Growth Factor Receptor Inhibitor Sorafenib
- (2010) I. M. E. Desar et al. JOURNAL OF NUCLEAR MEDICINE
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Colorectal cancer: cetuximab,KRAS,BRAF,PIK3CAmutations and beyond
- (2010) Christos Katsios et al. Expert Review of Gastroenterology & Hepatology
- Rapidly rising clinical trial costs worry researchers
- (2009) R. Collier CANADIAN MEDICAL ASSOCIATION JOURNAL
- Tumor Accumulation of Radiolabeled Bevacizumab due to Targeting of Cell- and Matrix-Associated VEGF-A Isoforms
- (2009) Thamar H. Stollman et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount
- (2009) Vladimir Tolmachev et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1
- (2009) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
- (2009) E. C.F. Dijkers et al. JOURNAL OF NUCLEAR MEDICINE
- Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
- (2009) David Olmos et al. LANCET ONCOLOGY
- Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
- (2009) A Gualberto et al. ONCOGENE
- HER-2/neu expression in primary and metastatic breast cancer
- (2008) Elyse E. Lower et al. BREAST CANCER RESEARCH AND TREATMENT
- Imaging liver metastases of colorectal cancer patients with radiolabelled bevacizumab: Lack of correlation with VEGF-A expression
- (2008) Marian G.W. Scheer et al. EUROPEAN JOURNAL OF CANCER
- Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts
- (2008) Kristin McLarty et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol
- (2008) L. M. Peterson et al. JOURNAL OF NUCLEAR MEDICINE
- Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET
- (2008) H. J.W.L. Aerts et al. JOURNAL OF NUCLEAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started